<i>Acinetobacter baumannii</i> : Pathogenesis, virulence factors, novel therapeutic options and mechanisms of resistance to antimicrobial agents with emphasis on tigecycline-Reference-Cited by-同舟云学术

Acinetobacter baumannii : Pathogenesis, virulence factors, novel therapeutic options and mechanisms of resistance to antimicrobial agents with emphasis on tigecycline

Published:2022-10-06 Issue:11 Volume:47 Page:1875-1884
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:Clinical Pharmacy Therapeu

Author:

Dehbanipour Razieh¹^ORCID,Ghalavand Zohreh¹^ORCID

Affiliation:

1. Department of Microbiology School of Medicine, Shahid Beheshti University of Medical Sciences Tehran Iran

Publisher

Hindawi Limited

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13787

Reference80 articles.

1. Acinetobacter baumannii

2. Acinetobacter baumannii : Emergence of a Successful Pathogen

3. Accurate identification of clinically important Acinetobacter spp.: an update

4. Dynamics of a Sporadic Nosocomial Acinetobacter calcoaceticus – Acinetobacter baumannii Complex Population

5. International Study of the Prevalence and Outcomes of Infection in Intensive Care Units

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous tigecycline with selected multichamber bag parenteral nutrition: A compatibility study;Journal of Parenteral and Enteral Nutrition;2024-09-10

2. Characterization and therapeutic potential of MRABP9, a novel lytic bacteriophage infecting multidrug-resistant Acinetobacter baumannii clinical strains;Virology;2024-07

3. An insight into MDR Acinetobacter baumannii infection and its pathogenesis: Potential therapeutic targets and challenges;Microbial Pathogenesis;2024-07

4. Stepwise Nitric Oxide Release and Antibacterial Activity of a Nitric Oxide Photodonor Hosted within Cyclodextrin Branched Polymer Nanocarriers;ACS Medicinal Chemistry Letters;2024-05-09

5. Therapies in preclinical and in early clinical development for the treatment of urinary tract infections: from pathogens to therapies;Expert Opinion on Investigational Drugs;2024-05-09